| Siminski, Suzanne M. |
Frontier Sci & Technology Rsch Fdn, Inc
United States |
CASCADE Coordinating Center |
5U24CA275417-03 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Simone, Donald |
University Of Minnesota
United States |
Neural Mechanisms of Cancer Pain |
5R01CA241627-05 |
|
Rachel Altshuler, Ph.D. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Cirrhosis in the United States |
5U01CA230694-05 |
|
|
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules |
5U01CA283935-02 |
|
Sidney Fu, M.D. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Clinical Validation Center for Hepatocellular Carcinoma |
5U01CA271887-03 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Screening for Hepatocellular Carcinoma in Patients with Cirrhosis |
5R01CA222900-06 |
|
|
| Skates, Steven J |
Massachusetts General Hospital
United States |
Proteomic Analyses of Serial Prediagnostic PLCO Serum in Cases and Controls to Identify Early Detection Ovarian Cancer Biomarkers Rising in a Substantial Fraction of Cases and Stable in Most Controls |
5U01CA260758-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Skates, Steven J |
Massachusetts General Hospital
United States |
Genome-wide methylation and proteomic analysis of uterine lavage and cervical swab for early detection of ovarian cancer |
5U2CCA271871-02 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Skubitz, Amy Patrice |
University Of Minnesota
United States |
A paradigm shift for ovarian cancer biomarkers: Utilizing routine Pap tests as liquid biopsies for the development of targeted mass spectrometry-based proteomic assays for early detection |
5R01CA262153-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Christos Patriotis, Ph.D., M.Sc. |
| Slager, Susan L |
Mayo Clinic Rochester
United States |
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) |
5R01CA258465-03 |
|
|